- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03599856
TraceBook: the Clinical Proof of Concept on the Intensive Care. (TraceBook)
Study Overview
Detailed Description
Method A prospective single center (Catharina Hospital Eindhoven) controlled before-and-after study.
The before period will be used as control group in which ward rounds and nurse handovers will be observed by the investigators for two months. Then TraceBook will be introduced and clinicians, ICU doctors and nurses, will be able to use checklists of TraceBook for ward rounds, their shifts and handovers in which they will be observed for two months. The goal is at least 120 observations per period.
Endpoints The primary outcome is the percentage of items that were checked per ward rounds and nurse handovers during the before and the after implementation period. Secondary outcomes will be clinical outcomes of admitted patients, pharmacist specific outcomes, specific checkable item related outcomes, and user experience and acceptance scores.
Hypothesis TraceBook, with the use of digital dynamic checklists, improves compliance to care processes on the intensive care with a high user acceptance score.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Noord-Brabant
-
Eindhoven, Noord-Brabant, Netherlands, 5623 EJ
- Catharina Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Physicians working on the ICU
- All admitted patients on the ICU during the study periods.
Exclusion Criteria:
- Physicians objecting participation in the trial
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: "Before" control group
Control group with observation of current local standard of care with paper checklist available at the bedside during the ICU rounds of the ICU physicians (as usual)
|
|
Experimental: "After" Intervention group
An mini Ipad providing TraceBook' intelligent dynamic clinical checklists during the ICU rounds of the ICU physicians.
|
TraceBook offers the user intelligent dynamic clinical checklist that shows patient specific items to a specific user while being context aware.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Checked items
Time Frame: 24 hours (each day)
|
The percentage of daily checked checkable items overall and items requiring an intervention per patient.
|
24 hours (each day)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mortality
Time Frame: 9 months
|
Intensive Care mortality
|
9 months
|
Mortality
Time Frame: 9 months
|
30 day mortality
|
9 months
|
Mortality
Time Frame: 9 months
|
90 day mortality
|
9 months
|
Length of stay
Time Frame: 9 months
|
Length of stay at the intensive care
|
9 months
|
Ventilator days
Time Frame: 9 months
|
Number of days with use of mechanical ventilator (per patient and overall per period)
|
9 months
|
Sedation days
Time Frame: 9 months
|
Number of patient days with a Richmond Agitation-Sedation Scale (score -5 till +4) between -5 and -1 as worse outcome.
|
9 months
|
Daily intensive care medication alerts
Time Frame: 4 months
|
Number of daily intensive care medication alerts for the pharmacist.
|
4 months
|
Pharmacists' interventions
Time Frame: 4 months
|
Types of pharmacists' interventions based on the daily intensive care medication alerts
|
4 months
|
Number of gastro-intestinal bleedings
Time Frame: 4 months
|
The number of patients during each period with hematemesis or melena, not being the reason of admission.
|
4 months
|
Ventilator and hospital associated pneumonia on the intensive care.
Time Frame: 4 months
|
The number of patients during each period with ventilator and hospital associated pneumonia, not being the reason of admission.
|
4 months
|
Central-venous-catheter-related bloodstream infections.
Time Frame: 4 months
|
The number of patients during each period with central-venous-catheter-related bloodstream infections, not being the reason of admission.
|
4 months
|
Incorrect prescribed anticoagulation or thrombosis prophylaxis.
Time Frame: 4 months
|
Number of patient days where anticoagulation or thrombosis prophylaxis is prescribed incorrect based on local protocol.
|
4 months
|
Incorrect prescribed proton pump inhibitors
Time Frame: 4 months
|
Number of patient days where proton pump inhibitors are prescribed incorrect based on local protocol.
|
4 months
|
Incorrect prescribed selective digestive decontamination
Time Frame: 4 months
|
Number of patient days where selective digestive decontamination is prescribed incorrect based on local protocol.
|
4 months
|
Spontaneous breathing trials
Time Frame: 4 months
|
Number of spontaneous breathing trials when required based on local protocol in weaning patients
|
4 months
|
Sedation wake up calls
Time Frame: 4 months
|
Number of sedation wake up calls when required based on local protocol
|
4 months
|
Intravenous sedatives use
Time Frame: 4 months
|
Number of patient days with the use of intravenous sedatives (eg Propofol, Midazolam)
|
4 months
|
Opiates use
Time Frame: 4 months
|
Number of patient days with the use of opiates overall and in patients with low Visual Analogue Scale scores (<4).
|
4 months
|
Antibiotics use
Time Frame: 4 months
|
Number of patient days with the use of antibiotics overall and when not required based on local protocol.
|
4 months
|
Complication registration
Time Frame: 4 months
|
Number of complications that were discussed within 24hrs and registered.
|
4 months
|
Energy deficit
Time Frame: 4 months
|
Number of patient days with energy deficit of >250.
|
4 months
|
Automatically checked items
Time Frame: 4 months
|
Number of items that where or could have been checked automatically during each period.
|
4 months
|
User experience outcomes
Time Frame: 6 months
|
Attrakdiff questionnaire after both periods Technology Acceptance Model 2 (TAM2) based questionnaire Semi-structured interview
|
6 months
|
Hedonic and pragmatic quality
Time Frame: 6 months
|
Attrakdiff questionnaire
|
6 months
|
User acceptance
Time Frame: 6 months
|
Technology Acceptance Model 2 (TAM2) based questionnaire after both periods to compare paper checklist and electronic health records with digital checklist and electronic health records.
|
6 months
|
User experience
Time Frame: 6 months
|
Semi-structured interview after the intervention period.
|
6 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Erik Korsten, Prof MD, Catharina Ziekenhuis Eindhoven
Publications and helpful links
General Publications
- De Bie AJR, Nan S, Vermeulen LRE, Van Gorp PME, Bouwman RA, Bindels AJGH, Korsten HHM. Intelligent dynamic clinical checklists improved checklist compliance in the intensive care unit. Br J Anaesth. 2017 Aug 1;119(2):231-238. doi: 10.1093/bja/aex129.
- De Bie AJR, Mestrom E, Compagner W, Nan S, van Genugten L, Dellimore K, Eerden J, van Leeuwen S, van de Pol H, Schuling F, Lu X, Bindels AJGH, Bouwman ARA, Korsten EHHM. Intelligent checklists improve checklist compliance in the intensive care unit: a prospective before-and-after mixed-method study. Br J Anaesth. 2021 Feb;126(2):404-414. doi: 10.1016/j.bja.2020.09.044. Epub 2020 Nov 17.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- nWMO-2018.61
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Critical Illness
-
Duke UniversityNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes...CompletedNeonatal Critical Illness | Pediatric Critical IllnessUnited States
-
Yale UniversityNational Institute on Aging (NIA)RecruitingCritical Illness | Illness, CriticalUnited States
-
McMaster UniversityLondon Health Sciences Centre; McMaster Children's Hospital; Canadian Critical...CompletedPediatric Critical IllnessCanada
-
Boston Children's HospitalCompleted
-
St Helens & Knowsley Teaching Hospitals NHS TrustManchester University NHS Foundation TrustCompleted
-
Sándor BeniczkyUniversity of Aarhus; Danish Council for Independent Research; Søster og Verner...CompletedCritical Illness Myopathy | Myopathy Critical IllnessDenmark
-
Hospital de Clinicas de Porto AlegreUnknownCritical Illness PolyneuropathiesBrazil
-
Peking Union Medical College HospitalBaxter Healthcare CorporationUnknownNutrition Therapy for Critical Illness
-
Assistance Publique - Hôpitaux de ParisRecruitingCritical Illness Related Corticosteroids InsufficiencyFrance
-
Yuzuncu Yıl UniversityKahramanmaras Sutcu Imam University; Izmir Ataturk Training and Research HospitalCompleted